Bcr-Abl mutations, resistance to imatinib, and imatinib plasma levels

Blood. 2003 Sep 1;102(5):1933-4; author reply 1934-5. doi: 10.1182/blood-2003-05-1629.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents / blood*
  • Antineoplastic Agents / therapeutic use*
  • Benzamides
  • Drug Resistance, Neoplasm
  • Genes, abl / genetics*
  • Humans
  • Imatinib Mesylate
  • Piperazines / blood*
  • Piperazines / therapeutic use*
  • Pyrimidines / blood*
  • Pyrimidines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate